BioCentury
ARTICLE | Clinical News

Cubist target validation technology

January 17, 2000 8:00 AM UTC

CBST developed peptides that bind to potential pathogen targets, combined with inducible expression of the peptides in a virulent bacterial strain, to validate targets derived from genomics. Expressio...